Skip to main content
    B

    bioAffinity Technologies, Inc. (BIAF)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $2.00
    -0.20 (-9.09%)

    Market Cap: $4.00M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    8%(1/12)
    Avg Surprise
    -24.63%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.14xFCF Yield-727.09%
    Profitability
    Profit Margin-278.90%Operating Margin-246.10%
    ROE-240.50%ROIC-376.12%
    Financial Health
    Debt/Equity0.05xInterest Coverage-306.74x
    Current Ratio1.51xQuick Ratio1.47x
    Trading Statistics
    Beta-1.05Avg Volume91.00K
    52-Week High$80.7052-Week Low$2.17

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 60.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.4, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.50
    SMA 20$2.81
    SMA 50$5.10
    SMA 200$18.32
    EMA 10$2.46
    EMA 20$2.97
    EMA 50$4.82
    EMA 200$19.10

    MACD

    Line: -0.76Signal: -0.83Hist: 0.07

    ADX

    ADX: 13.3+DI: 19.4-DI: 27.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$2.74

    Bollinger Bands

    Upper Band$3.69
    Lower Band$1.92
    %B Position6326%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    30.4

    Momentum Oscillators

    Stoch %K5.4
    Stoch %D9.5
    Williams %R-97.0
    ROC (10d)-33.1%
    Momentum-0.99
    CCI (20d)-156.0
    MFI (14d)60.1

    Volatility Measures

    ATR (14d)$0.57(28.7%)
    StdDev (20d)0.44
    Hist Vol112.7%(High)

    Volume Flow

    VWAP$2.04
    OBV1.4B
    AD Line2414.1B
    CMF (20d)-0.327

    Volume Metrics

    Avg Vol (20d)91.9K
    Vol Ratio0.8x
    VWMA (20d)$2.86

    Pivot Points

    R3$2.49
    R2$2.42
    R1$2.31
    Pivot Point$2.24
    S1$2.13
    S2$2.06
    S3$1.95

    Advanced Oscillators

    TSI-33.43
    Ultimate Osc29.4
    KST-452.93

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about BIAF

    News

    BIAF Valuation

    GNG's valuation label for BIAF is Undervalued.

    P/FCF
    -0.1x
    P/B
    0.5x
    All BIAF metrics

    BIAF Profitability: Margins, ROIC and FCF

    bioAffinity Technologies (BIAF) has a gross margin of 100.0%, an operating margin of -246.1% and a net margin of -278.9%. It posts -376.1% ROIC and a -235.9% FCF margin.

    Gross margin
    100.0%
    Operating margin
    -246.1%
    Net margin
    -278.9%
    ROIC
    -376.1%
    ROE
    -240.5%
    FCF margin
    -235.9%
    FCF yield
    -727.1%
    BIAF financial statements

    bioAffinity Technologies Competitors

    The companies most similar to bioAffinity Technologies (BIAF) include iSpecimen, MDxHealth SA and Bioatla.

    Sector: Healthcare

    Companies most similar to bioAffinity Technologies

    BIAF Bull Case vs Bear Case

    Bear case

    • BIAF has a -278.9% net profit margin.
    • BIAF beat EPS estimates in 12.5% of its last 8 reported quarters.
    • BIAF's quarterly revenue changed -26.0% year over year.

    BIAF Earnings: Beat Rate

    bioAffinity Technologies (BIAF) beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate (12.5%). Its next report is expected on Mar 11, 2027.

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -36.9%
    BIAF earnings history

    BIAF Earnings Date

    BIAF reports Mar 11, 2027. The date is estimated.

    BIAF ETF Holders

    Updated Nov 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About BIAF

    When does BIAF report earnings?

    bioAffinity Technologies, Inc. (BIAF) is expected to report earnings on Mar 11, 2027.

    Does BIAF pay dividends?

    bioAffinity Technologies, Inc. (BIAF) does not currently pay a regular dividend.

    What is BIAF's market cap?

    bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $4.00M with a current stock price of $2.00.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.